Harnessing multi-omics and artificial intelligence: revolutionizing prognosis and treatment in hepatocellular carcinoma

Harnessing multi-omics and artificial intelligence: revolutionizing prognosis and treatment in hepatocellular carcinoma

BackgroundHepatocellular carcinoma (HCC) is the most prevalent form of liver cancer, characterized by elevated mortality rates and heterogeneity. Despite advancements in treatment, the development of personalized therapeutic strategies for HCC remains a substantial challenge due to the intricate mol...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhen Wang, Gangchen Zhou, Rongchuan Cao, Guolin Zhang, Yongxu Zhang, Mingyue Xiao, Longbi Liu, Xuesong Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Immunology
Subjects:	hepatocellular carcinoma (HCC) multi-omics artificial intelligence-derived risk score (AIDRS) molecular subtypes sorafenib transcatheter arterial chemoembolization (TACE)
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1592259/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development and validation of a nomogram for predicting early recurrence in patients undergoing different courses of postoperative adjuvant transarterial chemoembolisation
by: Hongkun Tan, et al.
Published: (2025-06-01)

TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA ON ADVANCED LIVER CIRRHOSIS
by: A. S. Polekhin, et al.
Published: (2020-03-01)

Explainable machine learning model for predicting the transarterial chemoembolization response and subtypes of hepatocellular carcinoma patients
by: Yunjie Zhang, et al.
Published: (2025-07-01)

Evaluation of different scoring systems for repeating Transarterial Chemoembolization in Egyptian patients with Hepatocellular Carcinoma
by: Alhaddad Omkolsoum, et al.
Published: (2024-12-01)

Efficacy of sorafenib plus transcatheter arterial chemoembolization in treating hepatocellular carcinoma with portal vein tumor thrombosis: A meta-analysis
by: Xu Li, et al.
Published: (2024-09-01)

The prognostic value of AST-lymphocyte ratio index in liver cancer patients treated with TACE: a systematic review and single-center retrospective study
by: Yali Tian, et al.
Published: (2025-05-01)

Inter-reader agreement of RECIST and mRECIST criteria for assessing response to transarterial chemoembolization in hepatocellular carcinoma
by: Saeed Mohammadzadeh, et al.
Published: (2025-05-01)

Optimizing TACE for Hepatocellular Carcinoma: The Impact of Intra-Arterial Contrast Enhanced Ultrasound
by: Linda Galasso, et al.
Published: (2025-05-01)

Conventional transarterial chemoembolization followed by irreversible electroporation for hepatocellular carcinoma
by: Meng Zhao, et al.
Published: (2025-02-01)

Integrating multi-omics data to optimize immunotherapy in endometrial cancer: a comprehensive study
by: Xin Guan, et al.
Published: (2025-06-01)

TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis
by: Andrew M. Brown, et al.
Published: (2023-02-01)

Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study
by: Lingzhan Meng, et al.
Published: (2024-11-01)

Impact of Microparticle Transarterial Chemoembolization (mTACE) on myeloid‐derived suppressor cell subtypes in hepatocellular carcinoma: Clinical correlations and therapeutic implications
by: Yuanxun Yue, et al.
Published: (2024-09-01)

Molecular subtyping combined with multiomics analysis to study correlation between TACE refractoriness and tumor stemness in hepatocellular carcinoma
by: Qifan He, et al.
Published: (2025-02-01)

Successful long-term survival following lipiodol chemoembolization for hepatocellular carcinoma in Alagille syndrome: A case report
by: Imad Akasbi, MD, et al.
Published: (2025-08-01)

Identifying Subgroup at High Risk of Transarterial Chemoembolization Failure Among Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation
by: Edoardo Poli, et al.
Published: (2025-02-01)

Case Report: Three-year follow-up of TACE for recurrent undifferentiated pleomorphic sarcoma: sustained local control and no systemic progression
by: Xiangrui Chen, et al.
Published: (2025-08-01)

PGV-1 Causes Disarrangement of Spindle Microtubule Organization Resulting in Aberrant Mitosis in HLF and HuH6 Cells Associated with Altered MYCN Status
by: Nadzifa Nugraheni, et al.
Published: (2024-10-01)

Ischemic Stroke Post-Transradial Chemoembolization
by: Almamoon I. Justaniah, et al.
Published: (2024-01-01)

Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC
by: Xue Li, et al.
Published: (2024-12-01)

Transcatheter arterial infusion chemotherapy combined with lipiodol chemoembolization for advanced gastric fundus and cardia cancer with obstruction
by: Jiajia Zhang, et al.
Published: (2025-06-01)

Effectiveness of sorafenib in treating intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization
by: Reham Ashour, et al.
Published: (2024-11-01)

Efficacy of prophylactic dexamethasone in reducing post-embolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis
by: Rongli Li, et al.
Published: (2025-08-01)

HOTAIR Knockdown Increases the Sensitivity of Hepatocellular Carcinoma Cells to Sorafenib by Disrupting miR-145-5p/HK2 Axis-Mediated Mitochondrial Function and Glycolysis
by: Meiyu Cheng, et al.
Published: (2025-05-01)

GSTA1/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular carcinoma
by: Shiwen Ma, et al.
Published: (2024-12-01)

Identifying genes associated with Sorafenib resistance in hepatocellular carcinoma to develop risk model
by: Kuan He, et al.
Published: (2025-08-01)

Transarterial chemoembolization with or without sorafenib for hepatocellular carcinoma: A real-world propensity score-matched study
by: Tzu-Rong Peng, et al.
Published: (2022-01-01)

Clinicopathological features and treatment outcomes of patients with fibrolamellar hepatocellular carcinoma: a retrospective multicenter study
by: Ali Kaan Güren, et al.
Published: (2025-07-01)

Phase II study of transcatheter arterial chemoembolization (TACE) combined with apatinib for advanced perihilar cholangiocarcinoma
by: Hao Li, et al.
Published: (2025-07-01)

Application of intraluminal brachytherapy for malignant obstruction in the porta hepatis: a retrospective control study
by: Yi Zhang, et al.
Published: (2025-05-01)

CLCluster: A redundancy-reduction contrastive learning-based clustering method of cancer subtype based on multi-omics data
by: Hong Wang, et al.
Published: (2025-06-01)

A comparative analysis of the long-term efficacy between partial hepatectomy and transcatheter arterial chemoembolization in patients with liver metastasis from nasopharyngeal carcinoma
by: WANG Yilin, WANG Lu
Published: (2025-05-01)

Identification of metabolic reprogramming-related key genes in hepatocellular carcinoma after transcatheter arterial chemoembolization treatment
by: Tongfei Li, et al.
Published: (2025-05-01)

MOGAN for LUAD Subtype Classification by Integrating Three Omics Data Types
by: Haibin He, et al.
Published: (2025-04-01)

Pattern of extrahepatic collateral supply in recurrent hepatocellular carcinoma post-transcatheter arterial chemoembolization
by: Minatallah Elsadek, et al.
Published: (2025-05-01)

The delaying effect of toripalimab on disease progression in patients with advanced hepatocellular carcinoma and changes in serum tumor markers
by: Zhuo Yin, et al.
Published: (2025-07-01)

The Radiosensitizing Effect of Tumor-Derived Microparticles Co-Loaded with Sorafenib and Gold Nanoparticles on Hepatocellular Carcinoma
by: Yu L, et al.
Published: (2025-04-01)

Integrative Multi‐Omics Approaches Reveal Selectivity Profiles and Molecular Mechanisms of FIIN‐2, a Covalent FGFR Inhibitor
by: Ying Fu, et al.
Published: (2025-04-01)

3D synergistic tumor-liver analysis further improves the efficacy prediction in hepatocellular carcinoma: a multi-center study
by: Yurong Jiang, et al.
Published: (2025-01-01)

Thyroid metastasis from hepatocellular carcinoma: a rare case report and literature review
by: Shasha Guan, et al.
Published: (2025-06-01)